Deutsche Bank Downgrades Quest Diagnostics (DGX) to Hold; Lowers 2010-11 EPS Estimates
Tweet Send to a Friend
Deutsche Bank downgrades Quest Diagnostics (NYSE: DGX) from Buy to Hold. Price target $60.
Deutsche analyst says, "DGX has managed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Deutsche analyst says, "DGX has managed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
